Pfizer acquires Metsera for $10 billion, cementing their new obesity treatment strategy. The purchase concludes a weeklong bidding frenzy between the New York-based pharmaceutical company and Danish heavyweight Novo Nordisk, whose last-minute counterbid was finally rejected by US antitrust regulators.According to Reuters, Metsera’s board accepted a higher offer from Pfizer…
The past week has been one of extraordinary developments across politics, markets, and technology. From a historic mayoral election…
Shares in British real estate portal Rightmove plunged as much as 28% on Friday after the company warned of…
China’s newest and most advanced aircraft carrier, the Fujian, has officially entered service following a commissioning ceremony led by…
Oil prices are once again under moderate pressure, primarily due to the continued increase in global oil production easing…
Most non-agricultural commodities rose on the last day of the week with gold consolidating above the crucial mark of…
A top German general is sounding the alarm, warning that Russia could launch a limited strike on NATO territory…
Archer Aviation Inc (NYSE: ACHR) crashed roughly 20% this morning after announcing a $126 million acquisition of Hawthorne Airport…
President Trump met with Hungarian Prime Minister Viktor Orbán to discuss Hungary’s reliance on Russian oil and potential sanctions…
